TeaRx Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

TeaRx General Information

Description

Developer of therapeutic drugs intended to prevent deep venous thrombosis (DVT) and pulmonary embolism (PE). The company's drug is a new class of anticoagulants-blood coagulation factor Xa inhibitors and has a thioredoxin molecule that is required during the treatment of a range of diseases, as well as for the most surgical procedures, enabling medical institutions to prevent thromboembolism in patients and save lives.

Contact Information

Website
www.tearx.ru
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • Khimki 2a/1, Rabochaya Street
  • Building 1
  • Moscow, 141400
  • Russia
+7 8
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Khimki 2a/1, Rabochaya Street
  • Building 1
  • Moscow, 141400
  • Russia
+7 8

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

TeaRx Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 18-Aug-2026 Completed Out of Business
1. Early Stage VC Completed Clinical Trials - Phase 2
To view TeaRx’s complete valuation and funding history, request access »

TeaRx FAQs

  • When was TeaRx founded?

    TeaRx was founded in 2011.

  • Where is TeaRx headquartered?

    TeaRx is headquartered in Moscow, Russia.

  • What industry is TeaRx in?

    TeaRx’s primary industry is Drug Discovery.

  • Is TeaRx a private or public company?

    TeaRx is a Private company.

  • What is TeaRx’s current revenue?

    The current revenue for TeaRx is .

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process